BioVersys' Series A - II Round

BioVersys raised a round of funding on November 20, 2017.

BioVersys is a biopharmaceutical company committed to delivering long term value to patients and investors by developing new therapies to combat antimicrobial drug resistance, a major unmet medical ne…

Articles about BioVersys' Series A - II Round: